Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) has received an average recommendation of “Buy” from the nine analysts that are covering the firm, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy rating. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year […]
Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) has been assigned an average recommendation of “Buy” from the nine ratings firms that are presently covering the firm, Marketbeat reports. Nine equities research analysts have rated the stock with a buy rating. The average 1-year price target among brokerages that have updated their coverage on the […]
Cantor Fitzgerald restated their overweight rating on shares of Cabaletta Bio (NASDAQ:CABA – Free Report) in a report released on Friday, Benzinga reports. The firm currently has a $50.00 target price on the stock. Several other research analysts have also recently issued reports on the company. Wells Fargo & Company increased their price objective on […]
Cabaletta Bio (CABA) – Analysts Recent Ratings Changes themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Cabaletta Bio (NASDAQ:CABA – Free Report) had its price objective boosted by Citigroup from $26.00 to $30.00 in a research report report published on Thursday, Benzinga reports. Citigroup currently has a buy rating on the stock. CABA has been the subject of a number of other research reports. Wells Fargo & Company lifted their target […]